<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/wp-content/plugins/xml-sitemap-feed/assets/sitemap-news.xsl?ver=5.7.2"?>
<!-- generated-on="2026-06-09T14:57:05+00:00" -->
<!-- generator="XML Sitemap & Google News for WordPress" -->
<!-- generator-url="https://status301.net/wordpress-plugins/xml-sitemap-feed/" -->
<!-- generator-version="5.7.2" -->
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" >
<url><loc>https://www.pharmaglobenewswire.com/the-global-infusion-pumps-market-was-valued-at-usd-13-80-billion-in-2024-growing-at-a-cagr-of-9-54-to-reach-usd-23-85-billion-by-2032-estimates-delveinsight/</loc><news:news><news:publication><news:name>Pharma Globenewswire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-09T11:41:38+01:00</news:publication_date><news:title>The Global Infusion Pumps Market was valued at USD 13.80 billion in 2024, growing at a CAGR of 9.54% to reach USD 23.85 billion by 2032, estimates DelveInsight</news:title></news:news></url>
<url><loc>https://www.pharmaglobenewswire.com/chronic-refractory-cough-market-hits-8-5b-in-2024/</loc><news:news><news:publication><news:name>Pharma Globenewswire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-09T11:20:10+01:00</news:publication_date><news:title>Chronic Refractory Cough Market Hits $8.5B in 2024!</news:title></news:news></url>
<url><loc>https://www.pharmaglobenewswire.com/bone-marrow-failure-market-set-for-transformative-growth-driven-by-pipeline-innovation-rising-diagnosis-rates-and-expanding-therapeutic-landscape-through-2034/</loc><news:news><news:publication><news:name>Pharma Globenewswire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-09T10:33:51+01:00</news:publication_date><news:title>Bone Marrow Failure Market Set for Transformative Growth Driven by Pipeline Innovation, Rising Diagnosis Rates, and Expanding Therapeutic Landscape Through 2034</news:title></news:news></url>
<url><loc>https://www.pharmaglobenewswire.com/4775-2/</loc><news:news><news:publication><news:name>Pharma Globenewswire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-08T11:13:28+01:00</news:publication_date><news:title></news:title></news:news></url>
<url><loc>https://www.pharmaglobenewswire.com/pharmaceuticals-market-set-to-reach-usd-2435-53-billion-by-2032-driven-by-rising-disease-burden-rd-innovation-and-expanding-biologic-therapies/</loc><news:news><news:publication><news:name>Pharma Globenewswire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-08T05:47:41+01:00</news:publication_date><news:title>Pharmaceuticals Market Set to Reach USD 2,435.53 Billion by 2032, Driven by Rising Disease Burden, R&amp;D Innovation, and Expanding Biologic Therapies</news:title></news:news></url>
<url><loc>https://www.pharmaglobenewswire.com/gastroparesis-therapeutics-market-size-7mm-was-usd-150-million-in-the-us-in-2025-and-is-projected-to-grow-at-18-cagr-by-2036/</loc><news:news><news:publication><news:name>Pharma Globenewswire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-07T18:48:11+01:00</news:publication_date><news:title>Gastroparesis Therapeutics Market Size (7MM) was ~USD 150 Million in the US in 2025 and is projected to grow at ~18% CAGR by 2036</news:title></news:news></url>
</urlset>
